Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Growth hormone treatment does not augment the anti‐diabetic effects of liraglutide in UCD‐T2DM rats

Endocrinology Diabetes & Metabolism(2022)10.1002/edm2.392Source: DataRank Database

Growth hormone treatment does not augment the anti‐diabetic effects of liraglutide in UCD‐T2DM rats is a research paper published in Endocrinology Diabetes & Metabolism (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.25)OA: goldTopics (71)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Chad L. Cox,James L. Graham ORCID,Lotte Bjerre Knudsen ORCID,Kimber L. Stanhope ORCID,Kirsten Raun ORCID

Live enrichment

PubMed:36480511 PMC:PMC9836246 OpenAlex:https://openalex.org/W4310948575

National Institutes of Health

Grant: U24 DK092993

National Institutes of Health

Grant: HL‐107256

National Institutes of Health

Grant: HL‐091333

National Institutes of Health

Grant: HL‐075675

National Institutes of Health

Grant: AT‐003545

National Institutes of Health

Grant: AT‐002993

National Institutes of Health

Grant: 1RC1DK087307‐01

NIDDK NIH HHS

Grant: RC1 DK087307

National Institutes of Health

Grant: 5R01HL091333-05

Effects of 2wk fructose & HFCS consumption on lipid dysregulation & insulin resis

National Institutes of Health

Grant: 1R01HL075675-01A1

Dietary Fructose: Hormones &TG/Lipoprotein Metabolism

National Institutes of Health

Grant: 5R01HL107256-04

Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemia

National Institutes of Health

Grant: 1RC1DK087307-01

Surgical amelioration of type 2 diabetes: Hormones, microbiota and mitochondria

National Institutes of Health

Grant: 3U24DK092993-04S1

Mouse Metabolic Phenotyping Center (MMPC) at UC Davis

National Institutes of Health

Grant: 5K08HL003545-03

VEGF--PULMONARY VASCULAR LEAK IN ACUTE LUNG INJURY

National Institutes of Health

Grant: 5RC1DK087307-02

Surgical amelioration of type 2 diabetes: Hormones, microbiota and mitochondria

Novo Nordisk

FWCI

0.25

Citation Percentile

0.6%

Citation Trend

2022

2024

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/edm2.392

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/edm2.392

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.392

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/edm2.392

journalhttps://doi.org/10.1002/edm2.392

Fields of Study

Diabetes Treatment and ManagementPancreatic function and diabetesGrowth Hormone and Insulin-like Growth Factors0301 basic medicine03 medical and health sciences

MeSH Terms

LiraglutideAnimalsDiabetes Mellitus, Type 2GlucoseHumansInsulin ResistanceMaleGrowth HormoneWeight GainMiceRats

Keywords

LiraglutideEndocrinologyInternal medicineIncretinMedicineIsletInsulinDiabetes mellitusType 2 diabetesInsulin resistanceGlucagon-like peptide-1ObesityGrowth hormonefood intakeMaleType 2 (mesh)Clinical sciencesWeight GainMiceInsulin Resistance (mesh)2.1 Biological and endogenous factorsAnimals (mesh)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Research Articles3214 Pharmacology and Pharmaceutical Sciences (for-2020)Humans (mesh)DiabetesMice (mesh)Pharmacology and Pharmaceutical SciencesRats (mesh)5.1 PharmaceuticalsGrowth Hormone (mesh)Type 2610Diseases of the endocrine glands. Clinical endocrinologyLiraglutide (mesh)5.1 Pharmaceuticals (hrcs-rac)HumansAnimalsMetabolic and endocrineNutritionObesity (rcdc)Biomedical and Clinical Sciences2.1 Biological and endogenous factors (hrcs-rac)3202 Clinical sciences (for-2020)RC648-665Glucose (mesh)RatsNutrition (rcdc)GlucoseMetabolic and endocrine (hrcs-hc)Diabetes Mellitus, Type 2Diabetes (rcdc)Weight Gain (mesh)

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health